WuXi Biologics Reports Solid 2023 Annual Results ...Middle East

Revenue Increased by 11.6% Y-o-Y to RMB17,034.3 Million Gross Profit Rose by 1.5% to RMB6,827.9 Million Non-COVID Revenue Achieved 37.7% Y-o-Y Growth, Strong Momentum Sustained Non-COVID Late-Phase and Commercial Manufacturing Revenue Grew by 101.7% Y-o-Y "R" in CRDMO Thrived with...

Hence then, the article about wuxi biologics reports solid 2023 annual results was published today ( Tuesday 26/03/2024 - 04:57 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi Biologics Reports Solid 2023 Annual Results )

Also on site :

• EU must stop funding Kiev after Zelensky’s ‘insults’ – Italian MP
• The One Florida Hotel Family Travel Advisors Book on Repeat—and It’s Not Disney
• Why Is This Beloved 'Scrubs' Character Missing From the Reboot? Zach Braff Explains